EUROPEAN MULTIDISCIPLINARY ON UROLOGICAL CANCERS..

8th European Multidisciplinary Meeting on Urological Cancers

 

24 November - 27 November Milan
Close
N. Poster
Poster title
Applicant name
Status
  6-P Clinical performance of -2 pro-prostate-specific antigen and Prostate Health Index for prediction of prostate cancer in a cohort of Spanish men Angeles Sanchis-Bonet Received Received
  7-P Prostate cancer risk in relation to Insulin-like Growth Factor-1, IGF-Binding Protein-3 and Body Mass Index Angeles Sanchis-Bonet Received Received
  8-P What the urologist needs to know Adalgisa Guerra Received Received
  16-P Image guided radiotherapy with fiducial markers and intensity modulated radiotherapy in prostate cancer. Long terms outcomes Carmen Salas Received Received
  17-P Implementation and effects of three Dutch decision aids for prostate cancer: Results from the JIPPA study Julia van Tol-Geerdink Received Received
  22-P Laparoscopic salvage lymph node dissection in biochemical recurrence after radical prostatectomy and salvage radiotherapy. Feasibility, security, and results Teresa Renedo Villar Received Received
  24-P Implantations of fiducials gold markers in the prostate for Image Guided Radiotherapy. Experience of a university hospital Carmen Salas Received Received
  61-P Circulating tumor cells as liquid biopsies of prostate cancer bone metastases Karin Welén Received Received
  67-P Stereotactic body radiotherapy for nodal oligorecurrent prostate cancer: A multi-institutional analysis Piet Ost Received Received
  77-P Real-world outcomes of enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: A retrospective, multicenter study in Korea Minyong Kang Received Received
  78-P Is there still a place for docetaxel rechallenge in metastatic castrate resistant prostate cancer? Rodica Anghel Received Received
  86-P Impact of new therapies in the treatment of metastatic Castration Resistant Prostate Cancer (CPRCm): Retrospective analysis in a single institution in 2005-2015 Olatz Etxaniz Ulazia Received Received
  87-P Docetaxel chemotherapy in hormone-sensitive prostate cancer: A single-institution experience Mario Uccello Received Received
  88-P Laparoscopic salvage lymphadenectomy in patients treated with biochemical recurrence after radical prostatectomy after initially extended LND: Safety and objective response rate Sergey Reva Received Received
  89-P Salvage high-dose-rate brachytherapy for macroscopic local recurrence after radical prostatectomy David Buchser Received Received
  98-P Availability of prostate cancer rehabilitation resources and practice patterns: Results of a national survey Piet Ost Received Received
  100-P Urachal carcinoma: A retrospective analysis of a reference cancer center Ins Guerreiro Received Received
  121-P Baseline clinicopathological features as predictive markers of efficacy of Neoadjuvant Chemotherapy (NAC) in Muscle-Invasive Bladder Cancer (MIBC) Albert Font Pous Received Received
  124-P Preoperative neutrophil to lymphocyte ratio as a predictor marker of adverse outcomes in patients undergoing radical cystectomy due to bladder cancer Ariadna Fabià Mayans Received Received
  135-P The prognostic role of tissue TIMP-2 expression in patients with renal cell carcinoma Pastora Beardo-Villar Received Received
  137-P Long-term response to mTOR inhibitors (everolimus) in mRCC patients: Single institution experience Joanna Huszno Received Received
  139-P Comparison of sunitinib versus temsirolimus in patients with poor risk metastatic renal cell carcinoma David Sarid Received Received
  140-P Outcome of octogenarian versus young patients with metastatic renal cell carcinoma, treated with sunitinib David Sarid Received Received
  146-P Preoperative lipiodol marking improved safety and success rate on CT-guided cryoablation for small renal masses Fumiya Hongo Received Received
  149-P Impact of precise quantitative assessment of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy Ryuichi Mizuno Received Received
  155-P A double rare testicular cancer: Burned out tumor with vena cava thrombus presentation Pedro Oliveira Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30, Fri 8:30-15:00
18:07
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

EUROPEAN MULTIDISCIPLINARY ON UROLOGICAL CANCERS..

8th European Multidisciplinary Meeting on Urological Cancers

 

24 November - 27 November Milan
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 23/11/2016 TO 23/11/2016
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.EMUC2016.2016 
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 13/11/2016
Upload Poster
Upload Oral Presentation of Video
Check your Poster
Upload
Poster
Upload Oral
Presentation or Video
Check
your Poster




PosterSessionOnline
Logo Draft
 
Logo Cert